KN

Kayvan Niazi

NA Nantbio: 37 patents #1 of 51Top 2%
NI Nant Holdings Ip: 33 patents #12 of 93Top 15%
NA Nantcell: 19 patents #2 of 29Top 7%
NA Nantomics: 15 patents #4 of 38Top 15%
IM Immunitybio: 3 patents #11 of 38Top 30%
TR The Buck Institute For Age Research: 3 patents #2 of 12Top 20%
NA Nantkwest: 1 patents #8 of 11Top 75%
NA Nanocav: 1 patents #7 of 10Top 70%
NA Nantbioscience: 1 patents #11 of 18Top 65%
📍 Culver City, CA: #3 of 898 inventorsTop 1%
🗺 California: #2,909 of 386,348 inventorsTop 1%
Overall (All Time): #19,031 of 4,157,543Top 1%
87
Patents All Time

Issued Patents All Time

Showing 1–25 of 87 patents

Patent #TitleCo-InventorsDate
12416635 Live cell imaging systems and methods to validate triggering of immune response Shahrooz Rabizadeh, Nicholas J. Witchey 2025-09-16
12412639 Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samples Kevin B. Givechian, Kamil Wnuk, Chad Garner, Stephen Charles Benz, Hermes J. Garban +2 more 2025-09-09
12397019 Mesenchymal stem cell derived exosomes and methods Patrick Soon-Shiong, Francesco Curcio 2025-08-26
12385903 RP182 compositions and methods Patrick Soon-Shiong 2025-08-12
12350323 Cellular adjuvants for viral infection Raymond S. Wong, Peter Sieling, Philip T. Liu 2025-07-08
12329809 Cellular adjuvants for viral infection Raymond S. Wong, Peter Sieling, Philip T. Liu 2025-06-17
12311018 Targeted neoepitope vectors and methods therefor 2025-05-27
12308095 Prediction of computational pathway circuits Clifford Anders Olson, Nicholas J. Witchey, Wael Tadros 2025-05-20
12303477 HIV treatment compositions and methods Jeffrey Safrit, John H. Lee 2025-05-20
12290558 SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens Patrick Soon-Shiong, Peter Sieling, Shahrooz Rabizadeh, Lise Geissert, Annie Shin +4 more 2025-05-06
12285481 Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein Thomas H. King 2025-04-29
12280092 Reprogrammed T cell-like NK cells 2025-04-22
12263189 Mesenchymal stem cell derived exosomes and methods Patrick Soon-Shiong, Francesco Curcio 2025-04-01
12247086 Enhanced immunogenicity for GPI-anchored antigens Wael Tadros, Annie Shin 2025-03-11
12220452 Cellular adjuvants for viral infection Raymond S. Wong, Peter Sieling, Philip T. Liu 2025-02-11
12112838 Production and delivery tracking and sample verification of patient-specific therapeutics Nicholas J. Witchey 2024-10-08
12098201 Anti-TIM3 monoclonal antibodies and chimeric antigen receptors Clifford Anders Olson, Hermes J. Garban, Raymond S. Wong, Shiho Tanaka 2024-09-24
12098177 Targeted IL-12 treatments and methods to stimulate haNK and NK92mi cells Clifford Anders Olson, Shiho Tanaka, Heather McFarlane 2024-09-24
12094574 Difference-based genomic identity scores Nicholas J. Witchey, Patrick Soon-Shiong, John Zachary Sanborn 2024-09-17
12072337 Circulating tumor cell enrichment using neoepitopes Shahrooz Rabizadeh, Nicholas J. Witchey 2024-08-27
12060655 mRNA display antibody library and methods Clifford Anders Olson 2024-08-13
12053512 Method of validating the triggering of an immune response to a neoepitope of a tumor with t-cells Nicholas J. Witchey, Stephen Charles Benz, Shahrooz Rabizadeh 2024-08-06
12019067 Interferometry based systems to detect small mass changes of an object in a solution Krsto Sbutega 2024-06-25
12016883 Primary T-cell expansion Krsto Sbutega, Peter Sieling, Adam D. Lazar 2024-06-25
11939585 Multi-pulse transfection methods and cells Marcos SIXTO, Ting-Hsiang S. Wu, Chihwei Chang 2024-03-26